Asia-Pacific Hematology Consortium Report on approach to multiple myeloma. Survey results from the 6th International Hematologic Malignancies Conference: Bridging the Gap 2015, Beijing, China

• Published in: Leukemia & lymphoma Vol. 57; no. 7; pp. 1534 - 1538
• Main Authors: Lu, Jin, Hou, Jian, Liu, Kai-Yan, Parmar, Simrit, De La Fuente, Adolfo, Andersson, Börje, Yan, ChenHua, Zhou, Daobin, Tan, Daryl, Ritchie, David, Wu, Deipei, Shpall, Elizabeth, Laport, Ginna G., Li, JianYong, Hu, Jiong, Zhang, Lian Sheng, Wang, Michael, Malhotra, Pankaj, Jiang, Qian, Qin, Yazhen, Wong, Raymond, Champlin, Richard, Issaragrisil, Surapol, Iyer, Swaminathan, Mathews, Vikram, Wang, Yu, Hu, Yu, Xiao, Zhijian, Shao, Zonghong, Rosengarten, Rafael, Steuernagle, Jon, Xiao, Jun Huang, Orlowski, Robert, Chim, Chor Sang
• Format: Journal Article Conference Proceeding
• Language: English
• Published: United States Taylor & Francis 02.07.2016
• Subjects: APHCON; China; Humans; MDRing; Multiple Myeloma - diagnosis; Multiple Myeloma - therapy; Myeloma; survey; survey; Myeloma; APHCON; MDRing; China
• ISSN: 1042-8194; 1029-2403
• DOI: 10.3109/10428194.2015.1135434

The Asia-Pacific Hematology Consortium (APHCON), in partnership with MDRingTM, a mobile global physician education network, has initiated a detailed longitudinal study of physician knowledge and practice preferences in the Asia-Pacific sphere. The first dataset comes from a series of surveys answered by delegates at the APHCON Bridging The Gap (BTG) conference in Beijing in January, 2015. In this report we present our findings regarding diagnosis and treatment of multiple myeloma (MM). We aim to create a conduit for physicians in this region to share their experiences with the rest of the world, to identify areas of consensus and best practices, and to highlight opportunities for improvement in communication, education and patient care.